PROCEPT BioRobotics PRCT
NASDAQ PRCT
$20.38 +0.31 (+1.54%)
As of: Sep 11, 2026 · 3:59 PM EDT

PROCEPT BioRobotics (PRCT) Profit After Tax Growth (1y) (2021 - 2026)

Analysis

PROCEPT BioRobotics (PRCT) Profit After Tax Growth (1y) (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT Growth (1y) (Qtr)
1 Abbott Laboratories 178.01 Bn 172.41 Bn 7.27 Bn -47.84%
2 Intuitive Surgical 131.29 Bn 126.08 Bn 1.96 Bn 18.51%
3 Medtronic 116.38 Bn 107.56 Bn 6.34 Bn 41.26%
4 Stryker 106.01 Bn 102.53 Bn 4.50 Bn 44.34%
5 Boston Scientific 63.40 Bn 62.86 Bn 3.85 Bn 13.84%
6 Edwards Lifesciences 48.89 Bn 44.64 Bn 1.35 Bn -27.98%
7 Alcon 32.59 Bn 31.13 Bn 1.68 Bn -
8 Dexcom 31.84 Bn 29.89 Bn 830.00 Mn 38.54%
9 Steris 20.61 Bn 20.13 Bn 684.20 Mn 12.92%
10 PROCEPT BioRobotics 1.17 Bn 895.36 Mn 62.38 Mn -34.68%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -34.68%
Mar 31, 2026 -27.90%
Dec 31, 2025 -59.17%
Sep 30, 2025 -2.00%
Jun 30, 2025 22.17%
Mar 31, 2025 4.70%
Dec 31, 2024 31.81%
Sep 30, 2024 14.75%
Jun 30, 2024 -1.35%
Mar 31, 2024 8.87%
Dec 31, 2023 2.37%
Sep 30, 2023 -8.88%
Jun 30, 2023 -31.80%
Mar 31, 2023 -65.75%
Dec 31, 2022 -53.43%
Sep 30, 2022 -60.32%
Jun 30, 2022 -31.58%
Mar 31, 2022 -34.03%
Dec 31, 2021 -20.04%
Sep 30, 2021 -17.31%